OxySure (OXYS) Signs Distribution Agreement with Cardiac Life
Frisco, Texas, December 1, 2014 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company has signed a distribution agreement with Cardiac Life of Rochester, New York.
“Cardiac Life gives us strong representation in the northeast,” said Clark Hood, VP of Resuscitation Sales for OxySure. “They bring well over a decade of experience in the placement and management of thousands of AEDs throughout New York and surrounding areas. By adding OxySure to their product portfolio, they now can offer a unique and proprietary resuscitation product to their existing and new customers.”
Said Mary Wynne, President of Cardiac Life: “We are excited to add the OxySure Model 615 to our current product offering. We believe emergency oxygen is often overlooked when developing an emergency preparedness program due to the concerns of carrying oxygen tank systems. The Model 615 is FDA approved for OTC (over the counter) use and is a perfect companion product to new and existing AED programs. We can now offer a viable solution to our customers which make the administration of emergency oxygen simple and safe in the workplace. OxySure is a critical component in assuring a successful rescue and we are excited to be able to offer such a life supporting product to our customers.”
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
About Cardiac Life
Cardiac Life is a premier provider of AEDs and AED management services, operating since 2003 as a Certified Women Business enterprise and based in Rochester, New York. Cardiac Life is a major provider to local and state government as well as a major supplier to primary and secondary schools supporting their AED and management needs. An innovator in the field of Public Access Defibrillation, Cardiac Life has developed a proprietary web based management tool called AEDSafetrack to assure Public Access Defibrillation sites are both prepared for an emergency and compliant with federal and state law.
Forward-Looking Statements
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013.
Investor Contacts:
Stonegate Securities, Inc.
214-987-4121 / 972-294-6461
investors@oxysure.com
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
John Boidman: jboidman@renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989
Tags: